Date Filed | Type | Description |
12/20/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/20/2012 |
4
| Todisco Michael (Vice President, Controller) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| ODell William F (Exec. VP Sales and Marketing) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| MOLITEUS MAGNUS (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| MARCUS STUART L (VP, Sc. Aff & CMO) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| LUNDAHL SCOTT L (VP, Regulatory Affairs & IP) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| Hondros Paul J. (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| HAFT JAY M (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| Doman Robert F (President and CEO) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Unknown transaction of 138,286 shares
@ $8, valued at
$1.1M
Unknown transaction of 19,750 shares
@ $8, valued at
$158k
Unknown transaction of 528,400 shares
@ $8, valued at
$4.2M
Disposed/sold 50,000 options to buy
@ $14.26, valued at
$713k
Disposed/sold 50,000 options to buy
@ $15.9, valued at
$795k
Disposed/sold 50,000 options to buy
@ $6.75, valued at
$337.5k
Disposed/sold 60,000 options to buy
@ $3.37, valued at
$202.2k
Disposed/sold 28,500 options to buy
@ $2.2, valued at
$62.7k
Disposed/sold 187,400 options to buy
@ $1.22, valued at
$228.6k
Disposed/sold 130,000 options to buy
@ $1.65, valued at
$214.5k
|
|
12/20/2012 |
4
| CHRISTOPHER RICHARD (VP Finance & CFO) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| Casdin Alexander W. (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| CAROTA MARK (Vice President, Operations) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| BARTASH DAVID M (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC |
12/20/2012 |
4
| ALTOMARI ALFRED (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Unknown transaction of 10,000 shares
@ $8, valued at
$80k
Disposed/sold 15,000 options to buy
@ $2.34, valued at
$35.1k
|
|
11/13/2012 |
4
| CHRISTOPHER RICHARD (VP Finance & CFO) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Exercised 7,500 options to buy
@ $1.6, valued at
$12k
|
|
07/02/2012 |
4
| WURZER DAVID M (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Granted 8,000 shares
@ $0 |
|
07/02/2012 |
4
| MOLITEUS MAGNUS (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Granted 8,000 shares
@ $0 |
|
07/02/2012 |
4
| Hondros Paul J. (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Granted 8,000 shares
@ $0 |
|
07/02/2012 |
4
| HAFT JAY M (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Granted 8,000 shares
@ $0 |
|
07/02/2012 |
4
| Casdin Alexander W. (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Granted 8,000 shares
@ $0 |
|
07/02/2012 |
4
| BARTASH DAVID M (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Granted 8,000 shares
@ $0 |
|
07/02/2012 |
4
| ALTOMARI ALFRED (Director) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Granted 8,000 shares
@ $0 |
|
05/11/2012 |
4
| Todisco Michael (Vice President, Controller) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 872 shares
@ $6.13, valued at
$5.3k
|
|
05/11/2012 |
4
| ODell William F (Exec. VP Sales and Marketing) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 1,030 shares
@ $6.13, valued at
$6.3k
|
|
05/11/2012 |
4
| MARCUS STUART L (VP, Sc. Aff & CMO) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 1,172 shares
@ $6.13, valued at
$7.2k
|
|
05/11/2012 |
4
| LUNDAHL SCOTT L (VP, Regulatory Affairs & IP) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 872 shares
@ $6.13, valued at
$5.3k
|
|
05/11/2012 |
4
| Doman Robert F (President and CEO) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 1,506 shares
@ $6.13, valued at
$9.2k
|
|
05/11/2012 |
4
| CHRISTOPHER RICHARD (VP Finance & CFO) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 1,030 shares
@ $6.13, valued at
$6.3k
|
|
05/11/2012 |
4
| CAROTA MARK (Vice President, Operations) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 872 shares
@ $6.13, valued at
$5.3k
|
|
03/19/2012 |
4
| LUNDAHL SCOTT L (VP, Regulatory Affairs & IP) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Sold 7,976 shares
@ $5.75, valued at
$45.9k
Sold 1,900 shares
@ $5.76, valued at
$10.9k
Sold 5,224 shares
@ $5.8, valued at
$30.3k
Sold 800 shares
@ $5.81, valued at
$4.6k
Sold 1,600 shares
@ $5.84, valued at
$9.3k
Exercised 17,500 options to buy
@ $1.6, valued at
$28k
|
|
03/15/2012 |
4
| Todisco Michael (Vice President, Controller) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 2,203 shares
@ $5.86, valued at
$12.9k
|
|
03/15/2012 |
4
| ODell William F (Exec. VP Sales and Marketing) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 2,980 shares
@ $5.86, valued at
$17.5k
|
|
03/15/2012 |
4
| CAROTA MARK (Vice President, Operations) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 2,203 shares
@ $5.86, valued at
$12.9k
|
|
03/15/2012 |
4
| CHRISTOPHER RICHARD (VP Finance & CFO) has filed a Form 4 on DUSA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 2,980 shares
@ $5.86, valued at
$17.5k
|
|
|